Page 520 - medicina-integrativa_compress
P. 520

CAPÍTULO 47  SÍNDROME DE FATIGA CRÓNICA      525

             10.  Humulus lupus [Monograph]. Altern Med Rev 8:190-192, 2003.  24.  McKenzie R, O’Fallon A, Dale J, et al: Low-dose hydrocortisone for
             11.  Cronin JR: Passion flower: Reigniting male libido and other  treatment of chronic fatigue syndrome: A randomized controlled
                potential uses. Altern Complement Ther April:89-92, 2003.  trial. JAMA 280:1061-1066, 1998.
             12.  Dhawan K, Kumar S, Sharma A: Reversal of morphine tolerance and  25.  Teitelbaum JE, Bird B, Weiss A, et al: Low-dose hydrocortisone for
                dependence by passiflora incarnata. Pharmaceut Biol 40:576-580, 2002.  chronic fatigue syndrome. JAMA 281:1887-1888, 1999.
             13.  Hadley S, Petry JJ: Valerian. Am Fam Physician 67:1755-1758, 2003.  26.  Morales AJ, Nolan JJ, Nelson JC, et al: Effects of replacement dose
             14.  Yunus MB, Aldag JC: Restless legs syndrome and leg cramps in  of dehydroepiandrosterone in men and women of advancing age.
                fibromyalgia syndrome: A controlled study. BMJ 312:1339, 1996.  J Clin Endocrinol Metab 78:1360-1367, 1994.
             15.  Lowe JC, Garrison RL, Reichman AJ, et al: Effectiveness and safety   27.  Vliet EL: Screaming To Be Heard: Hormone Connections Women
                of T 3 therapy for euthyroid fibromyalgia: A double-blind, placebo-  Suspect ... and Doctors Ignore. New York, M. Evans & Company,
                controlled response driven crossover study. Clin Bull Myofasc Ther  1995.
                2:31-58, 1997                                   28.  Wright JV, Lenard L: Maximize Your Vitality and Potency, for Men
             16.  Lowe JC, Reichman AJ, Yellin J: The process of change during   over 40. New York, Smart Publications, 1999.
                T 3 treatment for euthyroid fibromyalgia: A double-blind, placebo-  29.  Ivker RS: Sinus Survival. New York, Tarcher/Putnam, 2000.
                controlled, crossover study. Clin Bull Myofasc Ther 2:91-124, 1997.  30.  Becker WM, Reece JB, Poenie MF, et al: The World of the Cell,
             17.  Faglia G, Bitensky L, Pinchera A, et al: Thyrotropin secretion in  3rd ed. San Francisco, Benjamin Cummings, 1996.
                patients with central hypothyroidism: Evidence for reduced  31.  Teitelbaum JE, Johnson C, St. Cyr JA: The use of D-ribose in chronic
                biological activity of immunoreactive thyrotropin. J Clin   fatigue syndrome and fibromyalgia: A pilot study. J Altern
                Endocrinol Metab 48:989-998, 1979.                  Complement Med 2006 [in press].
             18.  Skinner GRB, Holmes D, Ahmad A, et al: Clinical response to  32.  Regland B, Andersson M, Abrahamsson L, et al: Increased
                thyroxine sodium in clinically hypothyroid but biochemically  concentrations of homocysteine in the cerebrospinal fluid in patients
                euthyroid patients. J Nutr Environ Med 10:115-125, 2000.  with fibromyalgia and chronic fatigue syndrome. Scand J Rheumatol
             19.  Nordyke RA, Reppun TS, Madanay LD, et al: Alternative   26:301-307, 1997.
                sequences of thyrotropin and free thyroxine assays for routine  33.  Lindenbaum J, Rosenberg IH, Wilson PW, et al: Prevalence
                thyroid function testing: Quality and cost. Arch Intern Med 158:  of cobalamin deficiency in the Framingham elderly population.
                266-272, 1998.                                      Am J Clin Nutr 60:2-11, 1994.
             20.  Griep EN, Boersma JN, de Kloet ER: Altered reactivity of the  34.  Lindenbaum J, Healton EB, Savage DG, et al: Neuropsychiatric
                hypothalamic-pituitary axis in the primary fibromyalgia syndrome.   disorders caused by cobalamin deficiency in the absence of anemia
                J Rheumatol 20:469-474, 1993.                       or macrocytoses. N Engl J Med 318:1720-1728, 1988.
             21.  McCain GA, Tilbe KS: Diurnal hormone variation in fibromyalgia  35.  Beck WS: Cobalamin and the nervous system [Editorial]. N Engl J
                syndrome and a comparison with rheumatoid arthritis. J Rheumatol  Med 318:1752-1754, 1988.
                25:469-474, 1993.                               36.  Rowe PC, Bou-Holaigah I, Kan JS, et al: Is neurally mediated
             22.  Jefferies WM: Safe Uses of Cortisol, 2nd ed. Springfield, IL, Charles  hypotension an unrecognized cause of chronic fatigue?” Lancet
                C Thomas, 1996.                                     345:623-624, 1995.
             23.  Jefferies WM: Low-dosage glucocorticoid therapy: An appraisal of its  37.  Rowe PC, Calkins H, DeBush K, et al: Fludrocortisore acetate to
                safety and mode of action in clinical disorders, including  treat neurally mediated hypotension in chronic fatigue syndrome: A
                rheumatoid arthritis. Arch Intern Med 119:265-278, 1967.  randomized controlled trial. JAMA 285:52-59, 2001.















           © Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.
   515   516   517   518   519   520   521   522   523   524   525